Business Wire

NY-MEDIDATA

Share
Eisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced Eisai Inc. (“Eisai”), the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., as one of the first customers to harness its recently announced AI-driven Medidata Clinical Data Studio. Eisai Inc., will leverage this innovative data experience to gain unprecedented control over its clinical data, enable the execution of scalable and complex clinical trials, and enhance patient experience.

“We’ve included Medidata’s Clinical Data Studio in our clinical trial management platform given its ability to break down data silos and seamlessly integrate into our current software stack, while maintaining quality and integrity across all data sources,” said Shobha Dhadda, Ph.D. chief clinical science & operations officer, at Eisai. “Having a suite of technology solutions capable of processing diverse clinical and patient data types provides increased efficiencies without sacrificing quality or needing additional resources.”

Clinical Data Studio is powered by the Medidata Platform, the industry’s only unified platform that centrally manages all data sources, improving data reliability across the entire clinical trial ecosystem. By seamlessly integrating data from both Medidata sources, including Medidata Rave EDC, and non-Medidata sources, such as labs or another electronic data capture system, Clinical Data Studio streamlines the import process and enables automatic validation through configured data transfer agreements. Utilizing AI, it mitigates challenges posed by disparate data systems and offers up to 80 percent faster data review while providing a comprehensive view of patient data that can be concurrently reviewed, visualized, and acted on.

“Through Clinical Data Studio, Eisai is enabling healthcare stakeholders to overcome the complexities of modern clinical trials and foster collaboration on cleaner, more actionable data,” said Janet Butler, executive vice president, global head of sales, Medidata. “By delivering a unified AI-driven data management and analytics experience, we are enabling study teams to identify potential data issues faster and gain a more accurate understanding of the patient.”

About Medidata

Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 33,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across 2,200+ customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata.

About Dassault Systèmes

Dassault Systèmes is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and life-cycle-management processes of their offer and thus have a meaningful impact to make the world more sustainable. The beauty of the Experience Economy is that it is a human-centered economy for the benefit of all –consumers, patients and citizens. Dassault Systèmes brings value to more than 350,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit www.3ds.com.

© Dassault Systèmes. All rights reserved. 3DEXPERIENCE, the 3DS logo, the Compass icon, IFWE, 3DEXCITE, 3DVIA, BIOVIA, CATIA, CENTRIC PLM, DELMIA, ENOVIA, GEOVIA, MEDIDATA, NETVIBES, OUTSCALE, SIMULIA and SOLIDWORKS are commercial trademarks or registered trademarks of Dassault Systèmes, a European company (Societas Europaea) incorporated under French law, and registered with the Versailles trade and companies registry under number 322 306 440, or its subsidiaries in the United States and/or other countries. All other trademarks are owned by their respective owners. Use of any Dassault Systèmes or its subsidiaries trademarks is subject to their express written approval.

About Eisai Inc.

Eisai Inc., a human health care company, is the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd. headquartered in Nutley, N.J. Dedicated to oncology and neurology, its U.S. operations include research & development; manufacturing; global supply & logistics; and commercial activities. Learn more: https://us.eisai.com; Follow us on X and LinkedIn.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240724837236/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

comforte AG Warns of Impending March 2025 PCI DSS 4.0 Compliance Deadline11.2.2025 10:41:00 CET | Press release

comforte AG, a global leader in data security, today urged global businesses to finalize their PCI DSS 4.0 plans, ahead of the compliance deadline which falls on 31 March 2025. PCI DSS 4.0 is a major new iteration of the Payment Card Industry Data Security Standard, which applies to any organization which stores, processes or transmits cardholder data. As such, it has an outsized impact on sectors such as financial services and retail. The latest version features over 50 new technical requirements including new rules around data protection mechanisms. A key focus for PCI DSS 4.0 is to encourage cybersecurity as a long-term, continuous process, which is why additional flexibility has been baked into the standard—allowing organizations to choose the security controls most suited to their business. comforte’s tokenization technology is a proven, format-preserving way to safeguard cardholder data in line with PCI DSS 4.0, while preserving data utility. Because sensitive data elements like

Xsolla and AppsFlyer Unveil Custom Integration to Boost Mobile Game Web Shop Performance11.2.2025 10:00:00 CET | Press release

Industry First Collaboration Introduces Cross-Platform Analytics as an Integrated Solution to Solve Mobile and Web Measurement Challenges for Game Developers Xsolla, a leading global video game commerce company, has partnered with AppsFlyer, the global leader in mobile measurement, attribution, and data analytics, in a first-in-the-gaming industry web shop collaboration. This enhancement of the Xsolla and AppsFlyer partnership provides game developers with improved insights and simplified activation for its Web Shop solution, which is available worldwide. It also introduces solutions to address cross-platform measurement and attribution challenges. The partnership includes two integration options: server-to-server (S2S) and web integrations for mobile games. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250211661118/en/ (Graphic: Xsolla) Xsolla and AppsFlyer have collaborated closely for over a year to develop two custom in

Dragon Elements Breaks Free From Screens With LATIDO® Capsules11.2.2025 10:00:00 CET | Press release

SCALE Nanotech spins out Dragon Elements to bring graphene-based audiovisual technology to the XR and wearable electronics market SCALE Nanotech, an advanced R&D company based in Estonia, has announced the launch of its spinout Dragon Elements in Spain, marking a disruptive entry into the XR and wearable electronics sector. Dragon Elements is set to commercialize LATIDO® capsules, a revolutionary graphene-based technology designed to redefine human interaction with hardware by eliminating the need for traditional audio and video components. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250211733484/en/ The Birth of LATIDO®: A New Paradigm in Audiovisual Technology Derived from the Spanish word latido (heartbeat), LATIDO® encapsulates a radical shift in audiovisual hardware. Unlike conventional technology that requires separate components for sound and vision, LATIDO® harnesses millions of one-atom-thick graphene membranes t

Knauf Builds an Autonomous Supply Chain With Blue Yonder11.2.2025 10:00:00 CET | Press release

Global leader in building materials and construction systems chooses Blue Yonder to enhance supply chain agility and achieve strategic objectives leveraging AI and ML In the highly competitive and dynamic building materials and systems industry, manufacturers need to drive strategic growth and financial performance to succeed. That’s why Knauf, a globally leading manufacturer of building materials and construction systems, has chosen to deploy Blue Yonder Demand Planning, a cloud-native solution with cognitive capabilities that utilizes artificial intelligence (AI) and machine learning (ML). The solution will enable Knauf to gain access to industry-focused insights that enable faster decisioning and more precise forecasting to further transform its supply chain demand planning capabilities. The solution deployment is led by Blue Yonder Professional Services. Since 1932, Knauf has been synonymous with innovation, quality, and sustainability, boasting over 300 production sites in more th

KRAFTON Records All Time Highs in Sales (2.7098T KRW) and Operating Profit (1.1825T KRW) in 202411.2.2025 08:00:00 CET | Press release

Record-breaking earnings, with an average annual growth rate of sales reaching 20% over the past five yearsAims to hit 7T KRW in sales and double the corporate value by ‘securing a Big Franchise IP’Enhancing innovation in the global gaming industry via AI technology advancements KRAFTON, Inc. held an Investor Relations (IR) briefing on February 11, announcing its financial results for the fourth quarter and full year of 2024. According to consolidated financial statements under Korean International Financial Reporting Standards (K-IFRS), KRAFTON recorded 2.7098T KRW and operating profit (OP) of 1.1825T KRW for 2024, marking new all-time highs. These figures represent year-over-year (YoY) growth of 41.8% in sales and 54.0% in OP, driven by the continued expansion and sustainability of the PUBG IP, resulting in an average annual sales growth rate of 20% over the past five years. In the fourth quarter of 2024, KRAFTON recorded 617.6B KRW in sales and 215.5B KRW in OP, reflecting YoY incre

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye